ストックスクリーナーアプリを入手
11.85
0.68%
0.08
前日終値:
$11.77
開ける：
$11.85
24時間の取引高:
1.13M
Relative Volume:
0.36
時価総額：
$1.53B
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-19.11
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
-0.42%
1か月 パフォーマンス:
+18.50%
6か月 パフォーマンス:
+60.35%
1年 パフォーマンス:
-33.80%
1日の値動き範囲:
$11.73
$11.96
1週間の範囲:
$11.59
$12.20
52週間の値動き範囲:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
11.85 | 1.52B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
Bellevue Group AG Reduces Stake in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics Inc Stock Analysis and ForecastTake Profit Strategies & Start Your Free Trading Journey Today - earlytimes.in
The Supreme Industries Limited (SUPREMEIND) Announces Strategic ShiftValue Traps to Avoid & Get Ahead with Our Profit-Packed Picks - earlytimes.in
Will New RaDaR MRD Data and Myeloid Profiling Advances Change NeoGenomics' (NEO) Diagnostics Narrative? - simplywall.st
NeoGenomics to Present New ctDNA Research at SABCS 2025 - BioSpace
NeoGenomics (NEO): Assessing Valuation After a 44% Three-Month Share Price Rebound - Yahoo Finance
Quantbot Technologies LP Buys New Holdings in NeoGenomics, Inc. $NEO - MarketBeat
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025 - BioSpace
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies a - pharmiweb.com
Risk Hedge: Can NeoGenomics Inc NG9 stock sustain margin levelsJuly 2025 Fed Impact & Verified Short-Term Plans - moha.gov.vn
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) - The Globe and Mail
Personalized ctDNA detection and genomic profiling in the NeoRHEA Study - Nature
Is NeoGenomics Inc. (NG9) stock attractive for growth fundsWeekly Volume Report & Accurate Entry and Exit Point Alerts - Newser
How NeoGenomics Inc. stock benefits from tech adoptionJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Will NeoGenomics Inc. (NG9) stock announce a stock splitGlobal Markets & Free High Return Stock Watch Alerts - Newser
Greenhouse Funds LLLP Boosts Stock Holdings in NeoGenomics, Inc. $NEO - MarketBeat
Can NeoGenomics Inc. (NG9) stock deliver double digit returnsNew Guidance & Expert Approved Momentum Trade Ideas - Newser
NeoGenomics, Inc. $NEO Shares Bought by Samjo Management LLC - MarketBeat
Will NeoGenomics Inc. (NG9) stock announce special dividendOil Prices & Technical Confirmation Trade Alerts - Newser
Is NeoGenomics Inc. (NG9) stock supported by free cash flowWeekly Trend Report & Risk Adjusted Swing Trade Ideas - Newser
Can NeoGenomics Inc. (NG9) stock survive global slowdownMarket Risk Summary & Daily Entry Point Trade Alerts - Newser
Geode Capital Management LLC Buys 26,224 Shares of NeoGenomics, Inc. $NEO - MarketBeat
American Century Companies Inc. Has $25.71 Million Stock Position in NeoGenomics, Inc. $NEO - MarketBeat
Ideas Watch: How rising interest rates impact NeoGenomics Inc. stockJuly 2025 Gainers & Reliable Volume Spike Alerts - BỘ NỘI VỤ
Insider Selling: NeoGenomics (NASDAQ:NEO) EVP Sells 20,916 Shares of Stock - MarketBeat
Neogenomics EVP Olivo sells $250k in NEO stock By Investing.com - Investing.com Canada
Neogenomics EVP Olivo sells $250k in NEO stock - Investing.com India
NEOGENOMICS EVP Alicia C Olivo Sells Shares - TradingView
Is NeoGenomics Inc a good long term investmentMarket Breadth Indicators & Access Insider-Level Stock Analysis - earlytimes.in
What analysts say about NeoGenomics Inc stockDividend Aristocrats List & Free Professional Investment Consultations - earlytimes.in
NeoGenomics, Inc. (NEO) Stock Forecasts - Yahoo Finance
NeoGenomics Reports Strong Revenue Growth Amid Rising Losses - MSN
NeoGenomics Inc (NG9.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know - TradingView
First Week of January 2026 Options Trading For NeoGenomics (NEO) - Nasdaq
How NeoGenomics Inc. stock compares to market leadersWeekly Trade Review & Weekly Top Gainers Trade List - newser.com
Can NeoGenomics Inc. (NG9) stock sustain revenue momentumJuly 2025 Patterns & AI Powered Market Entry Strategies - newser.com
How hedge fund analytics apply to NeoGenomics Inc. stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
Is NeoGenomics Inc. stock a buy on dipsLayoff News & Smart Swing Trading Techniques - newser.com
Connor Clark & Lunn Investment Management Ltd. Takes Position in NeoGenomics, Inc. $NEO - MarketBeat
Is NeoGenomics Inc. (NG9) stock cheap by valuation metricsDividend Hike & Proven Capital Preservation Tips - newser.com
Earnings visualization tools for NeoGenomics Inc.2025 Earnings Impact & High Conviction Trade Alerts - newser.com
Will NeoGenomics Inc. (NG9) stock beat value stocksJuly 2025 Snapshot & Smart Allocation Stock Tips - newser.com
Will earnings trigger a reversal in NeoGenomics Inc.Buy Signal & Safe Capital Growth Plans - newser.com
Will NeoGenomics Inc. (NG9) stock beat Nasdaq index returns2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
NeoGenomics at Stephens Conference: Strategic Growth Amid Pharma Challenges By Investing.com - Investing.com Canada
Will NeoGenomics Inc. stock maintain dividend yieldTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
Price momentum metrics for NeoGenomics Inc. explainedJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
1.15%
0.39%
大文字化:
|
ボリューム (24 時間):